Clinical Trials List
2025-05-01 - 2030-12-01
Phase III
Recruiting5
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- Chun-Hui Lee 無
- Seu-Chun Yang 無
- Shang-Yin Wu 無
- Wu-Chou Su 無
- Chin-Wei Kuo 無
- 蔡政軒 無
- 林建佑
- Chian-Wei Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭家佑 無
- Ying-Ming Tsai Tsai 無
- 李玫萱 無
- 莊政皓 無
- Inn-Wen Chong 無
- Jen-Yu Hung 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jia-Shiuan Ju 無
- 邱立忠 無
- 黃振洋 無
- Chih-Liang Wang 無
- 林定佑 無
- Chih-Hung Chen 無
- Chan-Keng Yang 無
- Shih-Hong Li 無
- Ping-Chih Hsu 無
- Cheng-Ta Yang 無
- Chih-Hsi Kuo 無
- Chien-Ying Liu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
420 participants
